Boehringer Ingelheim Gubra to develop anti-obesity peptide poly agonists
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity.
It will bring together...
Lantheus, NanoMab to offer novel biomarker to develop immuno-oncology therapies
Lantheus Holdings has collaborated with NanoMab Technology to provide a novel biomarker for clinical development and management of immuno-oncology therapies.
As part of strategic collaboration...
Samsung BioLogics Enters New Era with First-of-its-kind Client-Centric CMO Deal
Samsung BioLogics (SBL) recently entered a new era by signing a "first of its kind" deal with a US bio-pharmaceutical company valued at $7.8...
GSK joins forces with the University of California to advance genomic research and improve drug discovery
GlaxoSmithKline plc announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research...
Savara Announces Results of IMPALA a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)
Savara Inc. , an orphan lung disease company announced top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an inhaled...
SCHOTT repeatedly increases production capacity for pharmaceutical tubing in India
The German technology group SCHOTT is investing an additional double-digit million-euro figure into a new glass tank at its tubing manufacturing plant in Jambusar,...
ICON Acquires Regional CRO for Patient Access in Europe and Africa
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, announced that it has acquired...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...